Study establishes first continuous real-time Barrett’s esophagus dysplasia automated detection AI algorithm
May 19, 2021 08:00 AM Eastern Daylight Time
IRVINE, Calif.–(BUSINESS WIRE)–Docbot, Inc., an artificial intelligence (AI) technology company focusing on gastrointestinal (GI) disease, today announced the following upcoming oral presentation at Digestive Disease Week (DDW) 2021, which takes place virtually May 21-23, 2021. The posters will be accessible on DDW’s ePosters and ePapers online portal beginning Friday, May 21, 2021.
“Strengths of these results, show that continuous real-time Barrett’s dysplasia automated detection using an AI algorithm is possible, the algorithm appears ready for prospective live real-time testing.”
Title: Detection of Early Esophageal Neoplasia in Barrett’s Esophagus using Real-Time Artificial Intelligence: A Multicenter External Video Validation Study
Abstract Number: 271
Presenter: Jason B. Samarasena, M.D., Associate Clinical Professor of Medicine
Program Director, Endoscopic Ultrasound/Interventional Endoscopy Training Program
Head of Advanced Endoscopic Imaging at UCI School of Medicine
Date/Time: Friday, May 21, 2021 from 5:30 PM to 7:00 PM Eastern
Session Type: Topic Forum
Session Title: Artificial Intelligence in Endoscopy
The aim of this study is to test a novel continuous real-time artificial intelligence algorithm to detect and localize dysplasia and early cancer during recorded endoscopy video of Barrett’s esophagus patients.
“We’re excited to present these results for the first time at DDW, as this external validation study shows promising results for a real-time AI algorithm demonstrating high sensitivity for dysplastic lesion detection while maintaining a low rate of false positive predictions,” said Jason Samarasena, M.D., lead investigator on the study and Associate Clinical Professor of Medicine, Division of Gastroenterology, University of California Irvine School of Medicine. “Strengths of these results, show that continuous real-time Barrett’s dysplasia automated detection using an AI algorithm is possible, the algorithm appears ready for prospective live real-time testing.”
DDW 2021 is being held virtually from May 21 to 23, 2021. Abstracts are expected to appear on DDW’s website in late April and in the May online supplement to Gastroenterology. ePosters and ePapers will be made available on this website during the congress. DDW is the world’s leading educational forum for clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.
Docbot, Inc. is an artificial intelligence technology company focusing on gastrointestinal (GI) disease. Docbot’s products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. UltivisionAI is an investigational device and has not received FDA clearance. For more information, visit www.docbot.ai.